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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
27.07.2020 Longitudinal 
analyses 
reveal 
immunological 
misfiring in 
severe 
COVID-19 
Nature | Article 
unedited 
 
• Longitudinal 
immunological 
correlates of disease 
outcome remain 
unclear 
• Immune profiling in 
113 C19 patients 
with moderate (non-
ICU) and severe 
(ICU) disease 
identified 
development of a 
maladapted immune 
response profile 
associated with 
severe C19 outcome 
and early immune 
signatures that 
correlate with 
divergent disease 
trajectories 
Immune 
response 
2 
 26.07.2020 Previous and 
active 
tuberculosis 
increases the 
risk of death 
and prolongs 
recovery in 
patients with 
COVID-19 
 medRxiv | pre-
print (not peer-
reviewed) 
• Longitudinal cohort 
analysis of matched 
C19 patients with 
and without TB, 
using C19 
surveillance data in 
the Philippines 
• Co-infection with TB 
increased morbidity 
and mortality in C19 
patients 
 TB co-
infection 
24.07.2020 Presence of 
genetic 
variants 
among young 
men with 
severe 
COVID-19 
JAMA | 
Preliminary 
Communication 
 
• A case series of 4 
young male patients 
with severe C19 
• A rare genetic 
variant were 
identified that were 
associated with 
impaired type I and 
II IFN responses 
genetics 
23.07.2020 Neonatal 
management 
and outcomes 
during the 
COVID-19 
pandemic: an 
observation 
cohort study 
 
The Lancet 
Child & 
Adolescent 
Health | Article 
 
• Perinatal 
transmission of C19 
is unlikely to occur if 
correct hygiene 
precautions are 
undertaken 
• Bearing in mind the 
benefits of early 
mother-neonate 
bonding and 
breastfeeding, 
allowing neonates to 
room in with their 
mothers and direct 
breastfeeding are 
safe procedures 
when paired with 
effective parental 
education of infant 
protective strategies 
neonates 
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Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.07.2020 Observations 
of the global 
epidemiology 
of COVID-19 
from the 
prepandemic 
period using 
web-based 
surveillance: 
a cross-
sectional 
analysis 
The Lancet 
Infectious 
Diseases | 
Article 
• Description of the global 
spread of SARS-CoV-2 
and characteristic of C19 
cases and clusters before 
the characterisation of C19 
as a pandemic 
• Cases with travel links to 
China, Italy or Iran 
accounted for almost two-
thirds of the first reported 
C19 cases from affected 
countries 
• Where age information is 
available – most were 
among adults aged 18 
years or older 
• There were many clusters 
of household transmission 
among early cases, but 
clusters were larger in 
occupational or community 
settings 
• This study also highlights 
the relatively late detection 
of SARS-CoV-2 in the 
WHO African region and 
remaining knowledge 
gaps, including paucity of 
case data from low-income 
countries 
Global 
spread, 
pre-
pandemic 
21.07.2020 Impact of 
self-imposed 
prevention 
measures 
and short-
term 
government-
imposed 
social 
distancing on 
mitigating 
the delaying 
a COVID-19 
epidemic: A 
PLOS 
Medicine | 
Article 
 
• This study compared the 
individual and combined 
effectiveness of self-
imposed prevention 
measures and of short-
term government-imposed 
social distancing in 
mitigating, delaying, or 
preventing a C19 epidemic 
• Results suggest 
information dissemination 
about proven self-imposed 
measures can be an 
effective strategy to 
mitigate and delay the 
epidemic 
• Early initiated short-term 
government-imposed 
social distancing can buy 
Prevention, 
individual, 
social 
distancing 
4 
modelling 
study 
time or healthcare systems 
to prepare for an 
increasing C19 burden 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
29.07.2020 SARS-CoV-2, 
SARS-CoV-1 
and MERS-
CoV viral load 
dynamics, 
duration or 
viral shedding 
and 
infectiousness: 
a living 
systematic 
review and 
meta-analysis 
medRxiv | 
pre-print (not 
peer-
reviewed) 
 
• Viral load kinetics and 
the duration of viral 
shedding are important 
determinants for disease 
transmission 
• Although SARS-CoV-2 
RNA shedding in 
respiratory and stool can 
be prolonged, duration 
of viable virus is 
relatively short-lived 
• Detection of viral RNA 
cannot be used to infer 
infectiousness 
• No study to date has 
detected live virus 
beyond day 9 of illness 
despite persistently high 
viral loads 
• SARS-CoV-2 viral load 
in the upper respiratory 
tract appears to peak in 
the first week of illness, 
while SARS-CoV-1 and 
MERS-CoV peak later 
• This study highlights the 
importance of early case 
finding and isolation 
Infectious 
virus, RNA 
 
30.07.2020 How to keep 
patients and 
staff safe from 
accidental 
COVID-19 
exposure in 
the emergency 
room: Lesson 
from South 
Korea’s 
explosive 
COVID-19 
outbreak 
Infection 
Control & 
Hospital 
Epidemiology 
| Article 
• An emergency room 
shutdown related to an 
accidental exposure to a 
patient with C19 who 
had not been isolated 
• Problematic accidental 
exposure and in-hospital 
transmission of COVID-
19 can be successfully 
prevented through 
active isolation and 
surveillance policy and 
comprehensive PPE use 
despite longer ER stays 
and the presence of 
more severely ill patients 
nosocomial 
 
5 
during an explosive C19 
outbreak 
• Paper included as a 
reminder to consider 
patient flow and 
nosocomial exposure 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.07.2020 Point-of-
care 
serological 
assays for 
delayed 
SARS-CoV-
2 case 
identification 
among 
health-care 
workers in 
the UK: a 
prospective 
multicentre 
cohort study 
The Lancet 
Respiratory 
Medicine | 
Article 
• Included to highlight that 
variation in performance 
characteristics between assays 
highlights the urgent need for 
individual evaluation of the 
large number of commercial 
SARS-Co-2 serology tests that 
have become rapidly available 
• Identification of false-negative 
results among HCWs suggest 
caution in interpretation of 
serology results at this early 
stage in the scale up of 
serology testing 
Serology 
testing 
Therapeutics 
Publication 
date 
Title/URL Journal/Articl
e type 
Summary             Keywords 
23.07.2020 Hydroxychloroqui
ne with or 
without 
Azithromycin in 
mild-to-moderate 
Covid-19 
  NEJM | 
Article 
• The use of 
hydroxychloroqui
ne, alone or with 
azithromycin, in 
patients 
hospitalised with 
mild-to-moderate 
C19 did not 
improve clinical 
status at 15 days 
compared with 
standard care 
 Hydroxychloroquin
e, azithromycin 
6 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
30.07.2020 Pandemic 
performance: 
women 
leaders in the 
Covid-19 
crisis 
Politics & 
Gender 
• Analysis of data on C19 
policy responses provided 
by the Coronavirus 
Government Response 
Tracker, combined with 
data on the gender of 
government leaders and 
the percentage of women 
in legislatures 
• There was no reliable 
evidence of policy 
difference across women 
and men in response to 
the pandemic  
• The share of women in 
legislatures is associated 
with a delay in closing 
schools, consistent with 
women policymakers 
placing a higher social and 
economic value on 
schools remaining open 
Women, 
leadership 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
22.07.2020 A tipping 
point for 
Yemen’s 
health 
system: 
the 
impact of 
COVID-
19 in a 
fragile 
state 
MedGlobal | 
Report 
• 27% mortality rate of Yemenis 
who are confirmed to have 
COVID-19 – more than 5 
times the global average and 
among the highest COVID-19 
mortality rate in the world 
• Disproportionate harm to 
health workers – 97 health 
workers have died in Yemen 
reportedly from C19 
• This report explores how C19 
is overwhelming the HS 
• Provides several 
recommendations based on 
information from health teams 
in Yemen 
Yemen 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
August 
2020 
The indirect impact of COVID-19 on women The Lancet Infectious Diseases | 
Newsdesk 
30.07.2020 New SARS-CoV-2 Vaccine Results, with 
Peter Piot 
NEJM | Audio interview 
29.07.2020 COVID-19 surfaces new directions for old 
challenges: three lasting ways to improve 
global health procurement 
CGD | Blog 
29.07.2020 Stockpiling of drugs: should the world care? CGD | Blog 
29.07.2020 ‘One big wave’ – why the Covid-19 second 
wave may not exist 
The Guardian | News 
29.07.2020 Roche provides an update on the phase II 
COVACTA trial of Actemra/RoActemra in 
hospitalised patients with severe COVID-19 
associated pneumonia 
Roche | Media release 
28.07.2020 Lung fibrosis: an undervalued finding in 
COVID-19 pathological series 
The Lancet Infectious Diseases | 
Correspondence 
28.07.2020 The challenges of informative wastewater 
sampling for SARS-CoV-2 must be met: 
lessons from polio eradication 
The Lancet Microbe | Comment 
27.07.2020 Impacts of COVID-19 on childhood 
malnutrition and nutrition-related mortality 
The Lancet | Comment 
27.07.2020 Child malnutrition and COVID-19: the time to 
act is now 
The Lancet | Comment 
27.07.2020 Eliminating viral hepatitis in the COVID-19 
era: weighing challenge and opportunity 
The Lancet Gastroenterology & 
Hepatology | Editorial 
8 
27.07.2020 The impact of COVID-19 on hepatitis 
elimination 
The Lancet Gastroenterology & 
Hepatology | Comment 
27.07.2020 COVID-19 and heatwaves: a double 
whammy for Indian cities 
The Lancet Planetary Health | 
Comment 
27.07.2020 Covid-19: Deaths in Yemen are five times 
global average as healthcare collapses 
BMJ | News 
25.07.2020 COVID-19 vaccine affordability and 
accessibility 
The Lancet | Correspondence 
25.07.2020 COVID-19 and China: lessons and the way 
forward 
The Lancet | Editorial 
25.07.2020 Pandemic science and politics The Lancet | Perspectives | Book 
24.07.2020 Molecular underpinnings of severe 
coronavirus disease 2019 
JAMA | Editorial 
24.07.2020 Particle sizes of infectious aerosols: 
implications for infection control  
The Lancet Respiratory 
Medicine| Viewpoint 
24.07.2020 The time to do serosurveys for COVID-19 is 
now 
The Lancet Respiratory Medicine 
| Comment 
24.07.2020 Need for sustainable biobanking networks for 
COVID-19 and other diseases of epidemic 
potential   
The Lancet Infectious Diseases | 
Personal View 
23.07.2020 COVID-19 response in Lebanon: Current 
experience and challenges in a low-
resources setting 
JAMA | Viewpoint 
23.07.2020 Vaccine preliminary results: here is why we 
need to exercise caution 
CGD | Blog 
23.07.2020 Management of mother-newborn dyads in 
the COVID-19 era 
The Lancet Child & Adolescent 
Health | Comment 
9 
21.07.2020 Can self-imposed prevention measures 
mitigate the COVID-19 epidemic? 
PLOS Medicine | Perspective 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-
19 
Vaccine 
Tracker 
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
10 
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health Topics Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
11 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedness 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
12 
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
13 
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
30.07.2020 
1440-1530 
BST 
The politics of 
vaccines: 
development and 
delivery 
Online event 1h 30 Blavatnik School of 
Government, University 
of Oxford 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
14 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
15 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
 
Suggested citation 
Millington, K.A. and Reddin, S. (2020). COVID-19 Health Evidence Summary No.86. K4D 
Evidence Summary. Brighton, UK: Institute of Development Studies. 
 
Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. It is 
licensed for non-commercial purposes only. K4D cannot be held responsible for errors, 
omissions or any consequences arising from the use of information contained in this health 
evidence summary. Any views and opinions expressed do not necessarily reflect those of 
DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020.               
 
 
